📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda. (2019)

First Author: Koopman JP

Attributed to: Immunomodulation and Vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/aasopenres.12972.2

PubMed Identifier: 31819922

Publication URI: http://europepmc.org/abstract/MED/31819922

Type: Journal Article/Review

Volume: 2

Parent Publication: AAS open research

ISSN: 2515-9321